Passive immunotherapy with convalescent COVID-19 plasma (CCP) is used as a
therapeutic procedure in many countries, including Serbia. In this study, we analyzed the …

Since December 2019, the human populations of the 195 global countries continue
experiencing grave health and life threats due to the current COVID-19 pandemic. As a …

Background and objectives COVID‐19 convalescent plasma is an experimental treatment
against SARS‐CoV‐2. The aim of this study is to assess the impact of different pathogen …

Background Convalescent plasma has been used for a long time for the treatment of various
infectious diseases. The principle is to collect antibody-containing plasma from recovered …

The novel coronavirus disease (COVID-19) has been declared a pandemic by the World
Health Organization (WHO) and is ominously threatening the survival of humankind on the …

The ongoing coronavirus disease 2019 (COVID-19) pandemic emerged in December 2019.
Convalescent plasma represents a promising COVID-19 treatment. Here, we report on the …

COVID-19 pandemic has imposed worldwide challenge and has significantly affected
transfusion medicine. Shortage in blood products along with concerns regarding the safety …

Background: Convalescent plasma is one of the treatment options for COVID-19 which is
currently being investigated in many clinical trials. Understanding of donor and product …

Coronavirus pandemic disease (COVID-19) is caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2). At the time of this paper writing, over 2, 5 million …

At the end of 2019, the pandemic, which originated in China, has become a major concern
all over the world. A new coronavirus, severe acute respiratory syndrome-related …